NovaBay Pharmaceuticals, Inc.(NYSE Amex Equities : NBY)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.80% | 61.58 | 0.0% | $914.89m | |
| NVAX | Novavax, Inc. | -5.99% | 98.30 | 102.0% | $790.47m | |
| AMGN | Amgen, Inc. | -0.62% | 251.59 | 1.3% | $725.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.08% | 640.34 | 2.5% | $677.64m | |
| GILD | Gilead Sciences, Inc. | -1.06% | 75.61 | 1.0% | $627.17m | |
| BIIB | Biogen, Inc. | 4.41% | 280.19 | 1.6% | $622.60m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.05% | 295.92 | 1.9% | $509.00m | |
| ILMN | Illumina, Inc. | -0.61% | 369.87 | 3.5% | $300.06m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.97% | 108.00 | 2.0% | $219.47m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.59% | 128.73 | 4.3% | $214.30m | |
| SGEN | Seattle Genetics, Inc. | -0.35% | 175.53 | 6.1% | $200.21m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.22% | 7.29 | 1.8% | $180.15m | |
| IMMU | Immunomedics, Inc. | 0.95% | 41.55 | 11.0% | $179.47m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.82% | 170.15 | 13.9% | $164.96m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.26% | 160.42 | 8.5% | $164.06m |
Company Profile
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.